Nuveen Real Estate Income Fund (JRS) Short Interest Ratio & Short Volume

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free JRS Stock Alerts

$7.15

+0.03 (+0.42%)

(As of 04:37 PM ET)

Compare

Nuveen Real Estate Income Fund Short Interest Data

Current Short Volume: 13,500 shares
Previous Short Volume: 10,400 shares
Change Vs. Previous Month: +29.81%
Dollar Volume Sold Short: $103,275.00
Short Interest Ratio / Days to Cover: 0.1
Last Record Date: February 15, 2024

Today's Trading Volume: 21,046 shares
Average Trading Volume: 86,462 shares
Today's Volume Vs. Average: 24%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling Nuveen Real Estate Income Fund ?

Sign up to receive the latest short interest report for Nuveen Real Estate Income Fund and its competitors with MarketBeat's FREE newsletter.

Short Interest Days to Cover Short Percent of Float

JRS Short Interest Over Time

JRS Days to Cover Over Time

JRS Percentage of Float Shorted Over Time

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Nuveen Real Estate Income Fund Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
2/15/2024	13,500 shares	$103,275.00	+29.8%	N/A	0.1	$7.65
1/31/2024	10,400 shares	$78,312.00	-46.1%	N/A	0.1	$7.53
1/15/2024	19,300 shares	$149,575.00	-59.0%	N/A	0.2	$7.75
12/31/2023	47,100 shares	$368,322.00	+39.4%	N/A	0.5	$7.82
12/15/2023	33,800 shares	$259,246.00	+64.9%	N/A	0.3	$7.67
11/30/2023	20,500 shares	$144,525.00	-13.1%	N/A	0.2	$7.05
Get the Latest News and Ratings for JRS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nuveen Real Estate Income Fund and its competitors with MarketBeat's FREE daily newsletter.
11/15/2023	23,600 shares	$161,660.00	-9.6%	N/A	0.3	$6.85
10/31/2023	26,100 shares	$161,037.00	-80.0%	N/A	0.3	$6.17
10/15/2023	130,200 shares	$864,528.00	+180.0%	N/A	1.6	$6.64
9/30/2023	46,500 shares	$311,550.00	+92.2%	N/A	0.6	$6.70
9/15/2023	24,200 shares	$169,279.00	+124.1%	N/A	0.3	$7.00
8/31/2023	10,800 shares	$78,840.00	-28.0%	N/A	0.1	$7.30
8/15/2023	15,000 shares	$109,050.00	+14.5%	N/A	0.2	$7.27
7/31/2023	13,100 shares	$101,263.00	+2,520.0%	N/A	0.2	$7.73
7/15/2023	500 shares	$3,805.00	-44.4%	N/A	0	$7.61
6/30/2023	900 shares	$6,687.00	-84.5%	N/A	0	$7.43
6/15/2023	5,800 shares	$42,398.00	-43.1%	N/A	0.1	$7.31
5/31/2023	10,200 shares	$71,808.00	+112.5%	N/A	0.1	$7.04
5/15/2023	4,800 shares	$34,752.00	-87.8%	N/A	0.1	$7.24
4/30/2023	39,300 shares	$296,322.00	+30.1%	N/A	0.5	$7.54
4/15/2023	30,200 shares	$221,668.00	-54.5%	N/A	0.4	$7.34
3/31/2023	66,300 shares	$495,261.00	+45.1%	N/A	0.8	$7.47
3/15/2023	45,700 shares	$338,180.00	-68.3%	N/A	0.5	$7.40
2/28/2023	144,000 shares	$1.20 million	+778.1%	N/A	1.6	$8.35
2/15/2023	16,400 shares	$141,532.00	+156.3%	N/A	0.2	$8.63
1/31/2023	6,400 shares	$55,808.00	-70.5%	N/A	0.1	$8.72
1/15/2023	21,700 shares	$179,893.00	+3.8%	N/A	0.3	$8.29
12/30/2022	20,900 shares	$158,004.00	-5.4%	N/A	0.2	$7.56
12/15/2022	22,100 shares	$176,800.00	-34.8%	N/A	0.2	$8.00
11/30/2022	33,900 shares	$287,133.00	+226.0%	N/A	0.4	$8.47
11/15/2022	10,400 shares	$84,656.00	-21.8%	N/A	0.1	$8.14
10/31/2022	13,300 shares	$104,937.00	+44.6%	N/A	0.2	$7.89
10/15/2022	9,200 shares	$66,332.00	No Change	N/A	0.1	$7.21
9/30/2022	30,800 shares	$238,084.00	+121.6%	N/A	0.4	$7.73
9/15/2022	13,900 shares	$123,154.00	-62.8%	N/A	0.2	$8.86
8/31/2022	37,400 shares	$356,422.00	+126.7%	N/A	0.5	$9.53
8/15/2022	16,500 shares	$170,940.00	+117.1%	N/A	0.2	$10.36
7/31/2022	7,600 shares	$75,164.00	-95.2%	N/A	0.1	$9.89
7/15/2022	157,700 shares	$1.48 million	-12.1%	N/A	1.6	$9.40
6/30/2022	179,300 shares	$1.69 million	-43.1%	N/A	2	$9.40
Tiny Biotech Stock Wins $75 Billion Patent (Ad) A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda. Find out more here >>>

JRS Short Interest - Frequently Asked Questions

What is Nuveen Real Estate Income Fund's current short interest?: Short interest is the volume of Nuveen Real Estate Income Fund shares that have been sold short but have not yet been covered or closed out. As of February 15th, traders have sold 13,500 shares of JRS short. Learn More on Nuveen Real Estate Income Fund's current short interest.
Is Nuveen Real Estate Income Fund's short interest increasing or decreasing?: Nuveen Real Estate Income Fund saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 13,500 shares, an increase of 29.8% from the previous total of 10,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Nuveen Real Estate Income Fund stock?: Short selling JRS is an investing strategy that aims to generate trading profit from Nuveen Real Estate Income Fund as its price is falling. JRS shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Nuveen Real Estate Income Fund?: A short squeeze for Nuveen Real Estate Income Fund occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of JRS, which in turn drives the price of the stock up even further.
How often is Nuveen Real Estate Income Fund's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JRS, twice per month. The most recent reporting period available is February, 15 2024.

More Short Interest Resources from MarketBeat

Related Companies:

Short Interest Tools:

This page (NYSE:JRS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Nuveen Real Estate Income Fund (JRS) Short Interest Ratio & Short Volume

Nuveen Real Estate Income Fund Short Interest Data

JRS Short Interest Over Time

JRS Days to Cover Over Time

JRS Percentage of Float Shorted Over Time

Nuveen Real Estate Income Fund Short Interest History

JRS Short Interest - Frequently Asked Questions

More Short Interest Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info